SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

DOG CRYPTO is trending following news of C2 Blockchain ($CBLO) significantly expanding its $DOG treasury, cementing its identity as a Bitcoin-native meme coin utilizing the Runes protocol. The community exhibits strong conviction, with a dedicated "DOG Army" proclaiming its long-term potential and superiority over other meme coins, while a vocal contingent dismisses it as a scam, forecasting further declines. This stark division fuels active debate surrounding its valuation and future in the crypto ecosystem.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Crypto is actively trending following the launch of its WolfSWAP, a cross-chain aggregator lauded by the community for its seamless functionality and potential for shared transaction fees. The Wolfpack is buzzing with bullish sentiment, foreseeing substantial growth driven by this utility and an even larger, innovative release anticipated in 2026, echoing early memecoin success stories.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros (OMER) is seeing significant market momentum following FDA approval for YARTEMLEA, the first and only approved therapy for transplant-associated thrombotic microangiopathy (TA-TMA). The community is celebrating this long-awaited milestone, anticipating substantial price appreciation and buyout potential, bolstered by the company's existing multi-billion dollar deal with Novo Nordisk and a strengthened financial position. This development signals a new era for Omeros with considerable commercial opportunities and pipeline validation.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is drawing significant attention as its circulating supply nears its maximum cap, fueling expectations of a potential 'supply shock' and treasury buybacks among bullish investors. This optimism is sharply contrasted by widespread community concerns regarding the Compound Foundation's financial health, governance challenges, and strong competition within the DeFi lending space.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RAVE CRYPTO is trending due to news surrounding Trumps World Liberty Financial's integration of Aster Trade into its USD1 expansion, which reportedly contributed to the RAVE token reaching a record high. The community is actively discussing the token's recent rally, with many highlighting its status as a relatively new coin with significant upside potential and limited legacy holders.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals is trending following FDA approval for Aqvesme, its treatment for anemia in alpha- or beta-thalassemia, making it the sole approved therapy for this rare blood disorder. While this represents a significant win with analysts adjusting price targets upwards, community discussion notes a mandated risk management program (REMS) requiring liver tests, with the drug's availability slated for early 2026.

xCellar is a DeFi protocol powered by the Fawkes Formula, providing untraceable and secure transactions on the blockchain. It's designed to give users complete financial privacy and control over their assets. The Fawkes Formula is our proprietary security protocol that forms the core of xCellar's untraceable transaction system. It utilizes advanced zero-knowledge proofs and cryptographic techniques to ensure complete anonymity.

Xcellar

Xcellar (XCL CRYPTO) is trending as its new privacy protocol launch and upcoming rewards system generate significant community buzz. Investors are highlighting its focus on anonymous transactions and perceived potential for substantial growth, particularly as the complementary Sentinel presale concludes and new features like a revamped dashboard are rolled out.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX, a 2x leveraged ETF for Super Micro Computer (SMCI), is trending as the community navigates its extreme volatility amidst a fluctuating AI server market. While many express long-term bullishness on SMCI's role in AI infrastructure, citing large orders and partnerships, intense debate revolves around SMCX's significant decay and the risks of holding leveraged positions. Traders are actively "buying the dip" with hopes for a strong rebound, contrasting sharply with concerns over past drawdowns and the potential for reverse splits.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is actively discussed due to significant institutional integrations, including its Cross-Chain Interoperability Protocol expanding as a key bridge for major financial institutions and wrapped asset transfers, alongside a Grayscale ETF launch. The community is sharply divided, debating LINK's foundational role in tokenized assets and the future of finance, with many seeing current levels as an undervaluation amidst broader market uncertainty.

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Baxter International Inc.

Baxter International is heavily discussed following an earnings report that featured a reduced financial outlook, largely attributed to production disruptions at a key facility. Adding to investor concerns, wider market anxieties persist regarding the potential impact of new weight-loss medications on the demand for dialysis treatments. This situation has positioned the stock at multi-year lows, fueling a divide among investors who see it as a compelling long-term value play amidst its strategic restructuring, versus those who remain cautious about persistent operational challenges and evolving sector dynamics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Karo Healthcare AB engages in the sale and marketing of products for everyday healthcare. The firm's portfolio includes brands across the following categories: intimate care, dermatology, footcare, pain, cough and cold, wellness, and prescription drugs. It operates through the following geographical segments: Sweden, Norway, Denmark, Finland, France, Germany, Italy, UK, Rest of Europe, USA, and Rest of World. The company was founded in 1987 and is headquartered in Stockholm, Sweden.

KARBF
Karo Pharma AB

Feed

News

Sentiment

Fundamentals

Info

Latest KARBF News

KARBFKaro Pharma AB